Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer

BACKGROUND: Although predictive value of immune‐related adverse events (irAEs) induced by immune checkpoint inhibitors (ICIs) have been suggested by several studies, their assessments were insufficient because patients were categorized only by the occurrence of irAEs. It has not been elucidated whet...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
প্রকাশিত:Oncologist
প্রধান লেখক: Akamatsu, Hiroaki, Murakami, Eriko, Oyanagi, Jun, Shibaki, Ryota, Kaki, Takahiro, Takase, Eri, Tanaka, Masanori, Harutani, Yuhei, Yamagata, Nao, Okuda, Yuka, Furuta, Katsuyuki, Sugimoto, Takeya, Teraoka, Shunsuke, Hayata, Atsushi, Tokudome, Nahomi, Ozawa, Yuichi, Mori, Keita, Koh, Yasuhiro, Yamamoto, Nobuyuki
বিন্যাস: Artigo
ভাষা:Inglês
প্রকাশিত: John Wiley & Sons, Inc. 2019
বিষয়গুলি:
Immuno‐Oncology
অনলাইন ব্যবহার করুন:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160399/
https://ncbi.nlm.nih.gov/pubmed/32297443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0299
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!

অনুরূপ উপাদানগুলি